SCHEMBL5382664

SCHEMBL5382664

CC(C)(c1ccccc1)c1ccc2nc(-c3ccccc3)oc(=O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.57
NPC1 O15118 6/20 0.51
RAB9A P51151 5/20 0.51
ALDH1A1 P00352 8/20 0.50
KDM4E B2RXH2 5/20 0.50
XBP1 P17861 1/20 0.50
HPGD P15428 3/20 0.48
KMT2A Q03164 2/20 0.48
F2 P00734 2/20 0.48
MAPT P10636 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HPN P05981 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14462683 0.97 NPC1 (0.55) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5380224 0.91 NPC1 (0.49) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5376751 0.90 KDM4E (0.51) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5378586 0.89 ALDH1A1 (0.66) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5385483 0.89 F7 (0.49) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5376982 0.88 RAB9A (0.46) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL14462682 0.88 F7 (0.45) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5382380 0.87 ALDH1A1 (0.69) ELANENPC1RAB9AALDH1A1KDM4E
SCHEMBL5381518 0.85 MAPT (0.54) NPC1RAB9AALDH1A1KDM4EXBP1
SCHEMBL5391365 0.84 ALDH1A1 (0.51) NPC1RAB9AALDH1A1KDM4EXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244776-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-07-17 US disclosed
US-7244776-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-07-17 US disclosed
US-20070100031-A1 Ultraviolet light absorbers RAVICHANDRAN RAMANATHAN 2007-05-03 US disclosed
US-20070100031-A1 Ultraviolet light absorbers RAVICHANDRAN RAMANATHAN 2007-05-03 US disclosed
US-7173128-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-02-06 US disclosed
US-7173128-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-02-06 US disclosed
US-20040192684-A1 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION 2004-09-30 US disclosed
EP-1430038-A1 ULTRAVIOLET LIGHT ABSORBERS Ciba SC Holding AG (CH) 2004-06-23 EP disclosed
WO-2003016292-A1 ULTRAVIOLET LIGHT ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192684-A1 Ultraviolet light absorbers UNG, MSH6, MAL2 ELANE 1702/4885NPC1 4195/4885RAB9A 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.